Skip to main content
PRFX
NASDAQ Life Sciences

Nasdaq Moves to Delist PRF Technologies After Sub-$1 Bid; Hearing Request Stays Suspension

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.786
Mkt Cap
$2.393M
52W Low
$0.641
52W High
$7.95
52W Position info
23% above low
Off High info
90% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

PRFX sits 23% above its 52-week low of $0.641 on light trading volume (0.2× avg).

Summary

Nasdaq's Listing Qualifications staff issued a delisting determination on November 9 after PRFX's closing bid stayed below $1.00 for 30 straight business days, from September 24 through November 4, 2026. The company gets no standard 180-day cure period because it already ran a 1-for-5 reverse split on February 6, 2026, inside the prior year. PRFX filed a timely hearing request before the November 16 deadline, which keeps the shares trading on the Nasdaq Capital Market under PRFX while the Panel decides. Management says it will pitch a compliance plan that may include another reverse split; the Panel can grant up to 180 days, or until May 8, 2027. The notice lands on top of an activist fight — S.H.N. Financial Investments petitioned a Tel Aviv court on November 2 to force a special meeting to replace most of the board — and a non-binding term sheet to sell the GridFeed/DeepSolar platform to Dotz. Interim CEO Efraim Cohen-Arazi cited roughly $11.0 million in cash and short-term deposits at September 30, 2026, and said LayerBio expects to start Phase 2 enrollment for OcuRing-K before year-end 2026. A delisting would hit liquidity and the company's ability to raise capital, and the stock already trades far below the $1 threshold.

At the time of this announcement, PRFX was trading at $0.79 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $0.64 to $7.95. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PRFX - Latest Insights

PRFX
Nov 13, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7834
Real-time Price: $0.740 info
Change: -$0.0434 (-6%) info
Market Cap: $2.381M info
PRFX
Nov 12, 2026, 4:31 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.7354
Real-time Price: $0.740 info
Change: +$0.0046 (+0.63%) info
Market Cap: $2.381M info
PRFX
Nov 05, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7588
Real-time Price: $0.740 info
Change: -$0.0188 (-2%) info
Market Cap: $2.381M info
PRFX
Nov 03, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7705
Real-time Price: $0.740 info
Change: -$0.0305 (-4%) info
Market Cap: $2.381M info
PRFX
Nov 03, 2026, 4:01 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.711
Real-time Price: $0.740 info
Change: +$0.029 (+4%) info
Market Cap: $2.381M info